Related coverage linked through entity extraction aliases.
Jul 01, 2026
A UTSW study shows post-exertion gait analysis can reveal lingering deficits in concussed youths, while UCLA Health expands biologic and regenerative therapies for athletes. These advances aim to improve recovery and return-to-play decisions.
Jul 31, 2026
A botanical moisturizer with oat and aloe outperformed metronidazole for rosacea erythema and lesions over 12 weeks. A separate study found nine risk factors for rosacea severity, including female sex, family history, and skin care habits.
Apr 01, 2026
INmune Bio will present new Phase III clinical data for its CORDStrom cell therapy for recessive dystrophic epidermolysis bullosa. The webinar on February 26, 2026, will feature investigators discussing outcomes including skin score improvements and quality-of-life measures. CORDStrom represents a systemic, disease-modifying alternative to topical treatments for this rare skin disorder.
